CalciMedica CALC
NASDAQ CALC
$1.11 +0.04 (+4.20%)
As of: Oct 21, 2026 · 1:13 PM EDT

CalciMedica (CALC) EBIT Margin (2024)

Updated

CalciMedica's EBIT Margin was -2884.11% in Q4 2024, down 252.92 percentage points from the prior quarter.

Analysis

CalciMedica (CALC) EBIT Margin (2024) Analysis & Trends

For FY2024, EBIT Margin at CalciMedica came in at -2386.98%.

  • Per Business Quant data, CALC's EBIT Margin in the three quarters before Q4 2024 was -2631.19% (Q3 2024), -2374.18% (Q2 2024) and -1878.50% (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 28.21%
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn 37.86%
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn 20.57%
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn -133.21%
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn 28.37%
10 CalciMedica 3.79 Mn -14.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,884.11%
Sep 30, 2024 -2,631.19%
Jun 30, 2024 -2,374.18%
Mar 31, 2024 -1,878.50%
API Access

CalciMedica EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CALC&period=max&api_key=YOUR_API_KEY